vanadates has been researched along with Chagas Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alho, I; Castiglioni, J; Correia, I; Costa Pessoa, J; Gambino, D; Marques, F; Mosquillo, MF; Pérez, L; Rostán, S; Scalese, G | 1 |
Avilés, FX; Benítez, J; Gambino, D; Garat, B; Guggeri, L; Lorenzo, J; Moreno, V; Pessoa, JC; Tomaz, I | 1 |
Atella, GC; Carneiro, AB; Cudischevitch, CO; Folly, E; Gazos-Lopes, F; Jablonka, W; Lima, LG; Machado, EA; Mendonça-Previato, L; Mesquita, RD; Monteiro, RQ; Nussenzveig, RH; Previato, JO; Ribeiro, JM; Romeiro, A; Senna, R; Silva-Cardoso, L; Silva-Neto, MA; Silveira, AB; Valenzuela, JG; Vanbeselaere, J | 1 |
3 other study(ies) available for vanadates and Chagas Disease
Article | Year |
---|---|
Heteroleptic oxidovanadium(IV) complexes of 2-hydroxynaphtylaldimine and polypyridyl ligands against Trypanosoma cruzi and prostate cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chagas Disease; Coordination Complexes; Humans; Male; Prostatic Neoplasms; Pyridines; Trypanocidal Agents; Trypanosoma cruzi; Vanadates | 2017 |
A novel vanadyl complex with a polypyridyl DNA intercalator as ligand: a potential anti-protozoa and anti-tumor agent.
Topics: Animals; Antineoplastic Agents; Antiprotozoal Agents; Apoptosis; Chagas Disease; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Intercalating Agents; Neoplasms; Phenazines; Trypanosoma cruzi; Vanadates | 2009 |
Glycoinositolphospholipids from Trypanosomatids subvert nitric oxide production in Rhodnius prolixus salivary glands.
Topics: Animals; Chagas Disease; Glycolipids; Host-Parasite Interactions; Insect Vectors; Nitric Oxide; Nitric Oxide Synthase Type I; Protein Tyrosine Phosphatases; Rhodnius; Salivary Glands; Trypanosoma cruzi; Trypanosoma rangeli; Vanadates | 2012 |